Evaluation and treatment of primary hyperparathyroidism [4] (multiple letters)

JAMA

Volumn 294, Issue 21, 2005, Pages 2699-2700

  Grey, Andrew ^a   Bolland, Mark ^a   Reid, Ian R ^a   Mikhail, Nasser ^b   Cope, Dennis ^c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Department of Endocrinology ^*

^c OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THIAZIDE DIURETIC AGENT;

BODY WEIGHT; CALCIUM EXCRETION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; ENDOCRINE SURGERY; GALLBLADDER DISEASE; GLUCOSE TOLERANCE; HUMAN; HYPERCALCEMIA; HYPERTENSION; LETTER; MALIGNANT NEOPLASTIC DISEASE; MEDICAL ASSESSMENT; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 28844492245     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.21.2699     Document Type: Letter

References (0)